Stocksigma LogoStocksigma Logo

Sai Parenterals to Acquire Majority Stake in Bion Therapeutics’ Prescription Business

Sai Parenterals Limited, via its wholly owned subsidiary SP Analytics, entered a definitive agreement on 16th Nov'26 to acquire a majority stake in Bion

Sai Parenterals to Acquire Majority Stake in Bion Therapeutics’ Prescription Business

Sai Parenterals Ltd · Press Release · 17 Nov 2026, 3:41 pm

Sai Parenterals to Acquire Majority Stake in Bion Therapeutics’ Prescription Business Sai Parenterals Limited, via its wholly owned subsidiary SP Analytics, entered a definitive agreement on 16th Nov'26 to acquire a majority stake in Bion Therapeutics India in an all-cash deal expected to close by late Nov'26. The acquisition adds 16 established branded formulations, ~250 field staff, ~20,000 doctor reach, and over 17,000 retail touchpoints across 12 states. Funded through internal accruals, debt, and IPO proceeds, the deal enables in-house manufacturing at TGA/WHO-GMP accredited facilities, expanding domestic commercial scale and margins.

Original exchange filing (PDF)

More announcements from Sai Parenterals Ltd

All Sai Parenterals Ltd announcements